Overview
Availability
- Professor Andrew Clouston is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
- Royal College of Pathologists of Australasia, Royal College of Pathologists of Australasia
Works
Search Professor Andrew Clouston’s works on UQ eSpace
2018
Journal Article
Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control
Patel, Preya Janubhai, Hossain, Fabrina, Horsfall, Leigh Ula, Banh, Xuan, Hayward, Kelly Lee, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Valery, Patricia Casarolli, Irvine, Katharine Margaret, Clouston, Andrew Donald, Stuart, Katherine Anne, Russell, Anthony William and Powell, Elizabeth Ellen (2018). Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control. Journal of Diabetes and its Complications, 32 (8), 799-804. doi: 10.1016/j.jdiacomp.2018.05.008
2018
Conference Publication
Recipient mucosal-associated invariant T cells control graft-versus-host-disease within the colon
Varelias, Antiopi, Bunting, Mark, Ormerod, Kate, Koyama, Motoko, Olver, Stuart, Straube, Jasmin, Kuns, Rachel, Robb, Renee, Henden, Andrea, Cooper, Leanne, Lachner, Nancy, Gartlan, Kate, Lantz, Olivier J., Kjer-Nielsen, Lars, Mak, Jeffrey, Fairlie, David, Clouston, Andrew, McCluskey, James, Rossjohn, Jamie, Lane, Steven, Hugenholtz, Phil and Hill, Geoff (2018). Recipient mucosal-associated invariant T cells control graft-versus-host-disease within the colon. Immunology 2018™ Meeting, Austin, TX United States, 4-8 May 2018. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.200.supp.55.15
2018
Journal Article
Recipient mucosal-associated invariant T cells control GVHD within the colon
Varelias, Antiopi, Bunting, Mark D., Ormerod, Kate L., Koyama, Motoko, Olver, Stuart D., Straube, Jasmin, Kuns, Rachel D., Robb, Renee J., Henden, Andrea S., Cooper, Leanne, Lachner, Nancy, Gartlan, Kate H., Lantz, Olivier, Kjer-Nielsen, Lars, Mak, Jeffrey Y. W., Fairlie, David P., Clouston, Andrew D., McCluskey, James, Rossjohn, Jamie, Lane, Steven W., Hugenholtz, Philip and Hill, Geoffrey R. (2018). Recipient mucosal-associated invariant T cells control GVHD within the colon. Journal of Clinical Investigation, 128 (5), 1919-1936. doi: 10.1172/JCI91646
2018
Journal Article
Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)
Burt, Alastair D, Alves, Venâncio, Bedossa, Pierre, Clouston, Andrew, Guido, Maria, Hübscher, Stefan, Kakar, Sanjay, Ng, Irene, Park, Young N, Reeves, Helen, Wyatt, Judith, Yeh, Matthew M and Ellis, David W (2018). Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 73 (3), 369-385. doi: 10.1111/his.13520
2018
Journal Article
PRV: where does the truth lie?
Low, It Wen, Harley, Hugh Alexander John and Clouston, Andrew (2018). PRV: where does the truth lie?. Gastroenterology, 155 (2), e7-e8. doi: 10.1053/j.gastro.2018.01.053
2018
Journal Article
Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis
Patel, Preya J., Banh, Xuan, Horsfall, Leigh U., Hayward, Kelly L., Hossain, Fabrina, Johnson, Tracey, Stuart, Katherine A., Brown, Nigel N., Saad, Nivene, Clouston, Andrew, Irvine, Katharine M., Russell, Anthony W., Valery, Patricia C., Williams, Suzanne and Powell, Elizabeth E (2018). Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis. Internal Medicine Journal, 48 (2), 144-151. doi: 10.1111/imj.13667
2018
Conference Publication
RNA-sequencing analysis of biopsies from chronic liver disease patients identifies gene signatures associated with progressive liver disease
Ramnath, D., Irvine, K., Lukowski, S., Horsfall, L., Loh, K., Clouston, A., Patel, P., Iyer, A., Lampe, G., Stow, J., Schroder, K., Fairlie, D., Powell, J., Powell, E. and Sweet, M. (2018). RNA-sequencing analysis of biopsies from chronic liver disease patients identifies gene signatures associated with progressive liver disease. International Liver Congress (ILC), Paris, France, 11-15 April, 2018. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0168-8278(18)31040-7
2018
Conference Publication
Advanced fibrosis is associated with longitudinal increases in Fibrosis-4 and NAFLD fibrosis scores
Patel, Preya, Cheng, Johnson Chieh-Yu, Banh, Xuan, Hossain, Fabrina, Horsfall, Leigh Ula, Hayward, Kelly Lee, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Stuart, Katherine A., Russell, Anthony William, Valery, Patricia Casarolli, Irvine, Katharine, Clouston, Andrew D., Bernard, Anne and Powell, Elizabeth E. (2018). Advanced fibrosis is associated with longitudinal increases in Fibrosis-4 and NAFLD fibrosis scores. Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) / Liver Meeting, San Francisco, CA United States, 9-13 November 2018. Hoboken, NJ United States: John Wiley & Sons. doi: 10.1002/hep.30257
2018
Conference Publication
Recipient mucosal-associated invariant T cells control graft-versus-host-disease within the colon
Varelias, Antiopi, Bunting, Mark, Ormerod, Kate, Koyama, Motoko, Olver, Stuart, Straube, Jasmin, Kuns, Rachel, Robb, Renee, Henden, Andrea, Cooper, Leanne, Lachner, Nancy, Gartlan, Kate, Lantz, Olivier J., Kjer-Nielsen, Lars, Mak, Jeffrey, Fairlie, David, Clouston, Andrew, McCluskey, James, Rossjohn, Jamie, Lane, Steven, Hugenholtz, Phil and Hill, Geoff (2018). Recipient mucosal-associated invariant T cells control graft-versus-host-disease within the colon. Immunology Meeting, Austin, TX, United States, 4-8 May 2018. Bethesda, MD United States: American Association of Immunologists.
2018
Journal Article
Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis
Maradana, Muralidhara Rao, Yekollu, Suman Kumar, Zeng, Bijun, Ellis, Jonathan, Clouston, Andrew, Miller, Gregory, Talekar, Meghna, Bhuyan, Zaied Ahmed, Mahadevaiah, Sachin, Powell, Elizabeth E., Irvine, Katharine M., Thomas, Ranjeny and O'Sullivan, Brendan John (2018). Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis. Metabolism: Clinical and Experimental, 78, 80-94. doi: 10.1016/j.metabol.2017.09.002
2018
Journal Article
Pathologic Features of Hereditary Cholestatic Diseases
Clouston, Andrew D. (2018). Pathologic Features of Hereditary Cholestatic Diseases. Surgical Pathology Clinics, 11 (2), 313-327. doi: 10.1016/j.path.2018.02.001
2017
Journal Article
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Balachandran, Vinod P., Łuksza, Marta, Zhao, Julia N., Makarov, Vladimir, Moral, John Alec, Remark, Romain, Herbst, Brian, Askan, Gokce, Bhanot, Umesh, Senbabaoglu, Yasin, Wells, Daniel K., Cary, Charles Ian Ormsby, Grbovic-Huezo, Olivera, Attiyeh, Marc, Medina, Benjamin, Zhang, Jennifer, Loo, Jennifer, Saglimbeni, Joseph, Abu-Akeel, Mohsen, Zappasodi, Roberta, Riaz, Nadeem, Smoragiewicz, Martin, Larkin Kelley, Z., Basturk, Olca, Gönen, Mithat, Levine, Arnold J., Allen, Peter J., Fearon, Douglas T., Merad, Miriam ... Bassi, Claudio (2017). Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature, 551 (7681), 512-516. doi: 10.1038/nature24462
2017
Journal Article
Alcohol consumption in diabetic patients with nonalcoholic fatty liver disease
Patel, Preya J., Smith, David, Connor, Jason P., Horsfall, Leigh U., Hayward, Kelly L., Hossain, Fabrina, Williams, Suzanne, Johnson, Tracey, Stuart, Katherine A., Brown, Nigel N., Saad, Nivene, Clouston, Andrew D., Irvine, Katharine M., Russell, Anthony W., Valery, Patricia C. and Powell, Elizabeth E. (2017). Alcohol consumption in diabetic patients with nonalcoholic fatty liver disease. Canadian Journal of Gastroenterology and Hepatology, 2017 (1) 7927685, 7927685-8. doi: 10.1155/2017/7927685
2017
Journal Article
A critical role for donor-derived IL-22 in cutaneous chronic GVHD
Gartlan, Kate H., Bommiasamy, Hemamalini, Paz, Katelyn, Wilkinson, Andrew N., Owen, Mary, Reichenbach, Dawn K., Banovic, Tatjana, Wehner, Kimberly, Buchanan, Faith, Varelias, Antiopi, Kuns, Rachel D., Chang, Karshing, Fedoriw, Yuri, Shea, Thomas, Coghill, James, Zaiken, Michael, Plank, Maximilian W., Foster, Paul S., Clouston, Andrew D., Blazar, Bruce R., Serody, Jonathan S. and Hill, Geoffrey R. (2017). A critical role for donor-derived IL-22 in cutaneous chronic GVHD. American Journal of Transplantation , 18 (4), 810-820. doi: 10.1111/ajt.14513
2017
Conference Publication
Are we done with the immunohistochemical classification of hepatocellular adenoma?
Raymond, Anne Aurelie, Le Bail, Brigitte, Paradis, Valerie, Ferrell, Linda, Sciarra, Amedeo, Yeh, Matthew M., Clouston, Andrew D., Miller, Gregory, Sempoux, Christine, Quaglia, Alberto, Gouw, Annette S., Thung, Swan N., Putra, Juan, Blanc, Jean-Frederic, Saltel, Frederic, Balabaud, Charles and Bioulac-Sage, Paulette (2017). Are we done with the immunohistochemical classification of hepatocellular adenoma?. 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) / Liver Meeting, Washington DC, United States, 20-24 October 2017. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1002/hep.29501
2017
Conference Publication
IL-17RB signaling is a critical contributor to hepatotoxin-induced liver fibrosis
Nalkurthi, B. C., Melino, M., Miller, G., Le Texier, L., Lineburg, K., Teal, B., Clouston, A. and Macdonald, K. P. A. (2017). IL-17RB signaling is a critical contributor to hepatotoxin-induced liver fibrosis. Gastroenterological Society of Australia Australian Gastroenterology Week Precision Medicine in Gastroenterology, Gold Coast, QLD, Australia, 20–22 August 2017. Richmond, VIC Australia: John Wiley and Sons. doi: 10.1111/jgh.13887
2017
Journal Article
Multimorbidity and polypharmacy in diabetic patients with NAFLD: implications for disease severity and management
Patel, Preya Janubhai, Hayward, Kelly Lee, Rudra, Rathiga, Horsfall, Leigh Ula, Hossain, Fabrina, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Clouston, Andrew Donald, Stuart, Katherine Anne, Valery, Patricia Casarolli, Irvine, Katharine Margaret, Russell, Anthony William and Powell, Elizabeth Ellen (2017). Multimorbidity and polypharmacy in diabetic patients with NAFLD: implications for disease severity and management. Medicine, 96 (26) e6761, e6761. doi: 10.1097/MD.0000000000006761
2017
Conference Publication
Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome
Varelias, Antiopi, Ormerod, Kate L., Bunting, Mark D., Koyama, Motoko, Gartlan, Kate H., Kuns, Rachel D., Lachner, Nancy, Locke, Kelly R., Lim, Chun Y., Henden, Andrea S., Zhang, Ping, Clouston, Andrew D., Hasnain, Sumaira Z., McGuckin, Michael A., Blazar, Bruce R., MacDonald, Kelli P.A., Hugenholtz, Philip and Hill, Geoff R. (2017). Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome. Immunology 2017™ Meeting, Washington, DC United States, 12-16 May 2017. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.198.supp.82.8
2017
Journal Article
Eomesodermin promotes the development of Type-1 Regulatory T (TR1) cells
Zhang, Ping, Lee, Jason S., Gartlan, Kate H., Schuster, Iona S., Comerford, Iain, Varelias, Antiopi, Ullah, Md Ashik, Vuckovic, Slavica, Koyama, Motoko, Kuns, Rachel D., Locke, Kelly R., Beckett, Kirrilee J., Olver, Stuart D., Samson, Luke D., Montes de Oca, Marcela, de Labastida Rivera, Fabian, Clouston, Andrew D., Belz, Gabrielle T., Blazar, Bruce R., MacDonald, Kelli P., McColl, Shaun R., Thomas, Ranjeny, Engwerda, Christian R., Degli-Esposti, Mariapia A., Kallies, Axel, Tey, Siok-Keen and Hill, Geoffrey R. (2017). Eomesodermin promotes the development of Type-1 Regulatory T (TR1) cells. Science Immunology, 2 (10) eaah7152. doi: 10.1126/sciimmunol.aah7152
2017
Conference Publication
Applying the Bordeaux classification for genotype-phenotype reclassification of resected hepatocellular adenomas in the greater Brisbane region from 2000 to 2015
Manoharan, B., Miller, G., McKay, B., Campbell, C., Bryant, R., Clouston, A. and O'Rourke, N. (2017). Applying the Bordeaux classification for genotype-phenotype reclassification of resected hepatocellular adenomas in the greater Brisbane region from 2000 to 2015. Sixteenth Annual Americas Hepato-Pancreat-Biliary Congress, Miami Beach, FL United States, 29 March – 2 April 2017. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.hpb.2017.02.053
Funding
Supervision
Availability
- Professor Andrew Clouston is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Supervision history
Completed supervision
-
2013
Doctor Philosophy
The pathogenesis of non-alcoholic fatty liver disease: From parenchymal injury to portal fibrosis
Principal Advisor
Other advisors: Professor Elizabeth Powell
-
2019
Doctor Philosophy
Defining cellular and molecular mediators of liver fibrosis
Associate Advisor
-
2015
Doctor Philosophy
Characterisation of Infiltrating Inflammatory Cells in the Development of Liver Injury and Progressive Fibrosis
Associate Advisor
Other advisors: Dr Katharine Irvine, Professor Elizabeth Powell
Media
Enquiries
For media enquiries about Professor Andrew Clouston's areas of expertise, story ideas and help finding experts, contact our Media team: